GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...

A drug that can be taken orally could soon rival the likes of Ozempic for treating type 2 diabetes and obesity, according to ...

SHOPPING: If you're tired of struggling to lose weight, you may just need a little help - and Hers makes it simpler than ever ...

WEIGHT loss, warding off dementia, ‘curing’ diabetes and now… anti-ageing powers? Is there anything the so-called fat jabs ...

The MHRA has revealed it's received more than 560 reports of acute pancreatitis in patients taking GLP-1 injections since ...

The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...

Already a household name in diabetes and weight management, Ozempic (semaglutide) may soon find another surprising role — as ...

People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, ...

In a paper released in Addiction, scientists reported that people with a history of alcohol use disorder who were prescribed ...

From 1 July, the weight-loss drug Wegovy will become available from Belgian pharmacists on prescription. This means Wegovy is ...

The popular diabetes drug Ozempic may cause temporary hair loss through rapid weight loss and nutritional changes. Medical ...